Skip to Content
Diagnosed with Prostate Cancer? Learn about your treatment options >>

Nilutamide Pregnancy and Breastfeeding Warnings

Nilutamide is also known as: Nilandron

Medically reviewed on Aug 6, 2018

Nilutamide Pregnancy Warnings

There are insufficient animal toxicity data. There are no controlled data in human pregnancy.

US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

This drug is not indicated for use in female patients.

AU TGA pregnancy category: Not assigned
US FDA pregnancy category: C

See references

Nilutamide Breastfeeding Warnings

This drug is not indicated for use in female patients.

Excreted into human milk: Unknown
Excreted into animal milk: Data not available

Comments: The effects in the nursing infant are unknown.

See references

References for pregnancy information

  1. "Product Information. Nilandron (nilutamide)." Hoechst Marion-Roussel Inc, Kansas City, MO.
  2. Cerner Multum, Inc. "Australian Product Information." O 0

References for breastfeeding information

  1. "Product Information. Nilandron (nilutamide)." Hoechst Marion-Roussel Inc, Kansas City, MO.
  2. Cerner Multum, Inc. "Australian Product Information." O 0

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide